GV

Verve Therapeutics Launches with $58.5 Million in Series A Funding Led by GV

CAMBRIDGE, MA–Verve Therapeutics, a next-generation cardiovascular company, announced its launch to discover and develop therapies that safely edit the adult…

Read More »